Validation of novel patient-centred juvenile idiopathic arthritis-specific patient-reported outcome and experience

Laura E Lunt1,2, Stephanie Shoop-Worrall1,3, Nicola Smith4

  • 1Versus Arthritis Centre for Epidemiology, Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK.

Insights

Patient-reported outcome and experience measures (PROM/PREM) for juvenile idiopathic arthritis (JIA) are validated and feasible for UK clinical use. Routine collection can improve patient-centered care quality for children with JIA.

Area of Science:

  • Paediatric Rheumatology
  • Health Outcomes Research
  • Patient-Reported Measures

Background:

  • Measuring outcomes important to children and young people (CYP) with juvenile idiopathic arthritis (JIA) is crucial for patient-centered care improvements.
  • This study validates novel JIA patient-reported outcome and experience measures (PROM and PREM) from the CAPTURE-JIA project across two UK centres.

Purpose of the Study:

  • To validate the CAPTURE-JIA Patient-Reported Outcome Measure (PROM) and Patient-Reported Experience Measure (PREM) for children and young people with JIA.
  • To assess the truth, discrimination, and feasibility of the newly developed measures.

Main Methods:

  • Recruited CYP with JIA from paediatric rheumatology clinics, administering CAPTURE-JIA PROM/PREM, CHAQ, and CHU 9D.
  • Conducted cognitive interviews and test-retest reliability assessments for PROM/PREM.
  • Applied OMERACT filter criteria, assessing truth (cognitive interviewing, sensitivity analysis, correlations) and discrimination (specificity, reliability).

Main Results:

  • Eighty-two CYP participated; PROM/PREM were understood and covered important areas.
  • PROM showed high sensitivities (>70%) against CHU 9D items (except fatigue) and moderate to very strong correlations (0.40-0.82).
  • High specificities (>70%) were observed for PROM/PREM domains; feasibility was confirmed with short completion times (PROM: 60s, PREM: 49s).

Conclusions:

  • The CAPTURE-JIA PROM and PREM are valid and feasible for use in UK paediatric rheumatology settings.
  • Routine implementation of these measures can significantly enhance the quality of care for children with JIA.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.9K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.0K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
263
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
189
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
316
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.3K